Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Annamycin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moleculin Gets Canadian Patent Allowance For Annamycin
    Moleculin Gets Canadian Patent Allowance For Annamycin

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156298/0/en/Moleculin-Announces-Notice-of-Allowance-for-Canadian-Patent-Covering-Annamycin.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Moleculin Begins Phase 3 Trial in EU for Acute Myeloid Leukemia
    Moleculin Begins Phase 3 Trial in EU for Acute Myeloid Leukemia

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3146083/0/en/Moleculin-Doses-First-EU-Patient-in-Phase-3-Pivotal-MIRACLE-Trial-for-Treatment-of-Acute-Myeloid-Leukemia.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    Moleculin to Get New European Patent for Annamycin
    Moleculin to Get New European Patent for Annamycin

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3124080/0/en/Moleculin-Receives-Notice-of-Intent-to-Grant-New-European-Patent-for-Annamycin.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share
    Moleculin Reports Positive Ph1B/2 Data for Annamycin in STS Lung
    Moleculin Reports Positive Ph1B/2 Data for Annamycin in STS Lung

    04 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/04/3093575/0/en/Moleculin-Reports-Positive-Topline-Efficacy-Results-from-U-S-Phase-1B-2-Clinical-Trial-Evaluating-Annamycin-for-the-Treatment-of-Soft-Tissue-Sarcoma-Lung-Metastases-MB-107.html

    GLOBENEWSWIRE
    04 Jun 2025
    Share Share
    WHO Approves Naxtarubicin As INN For Annamycin
    WHO Approves Naxtarubicin As INN For Annamycin

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3075142/0/en/Moleculin-Announces-World-Health-Organization-Approval-of-naxtarubicin-as-International-Non-Proprietary-Name-for-Annamycin.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share
    Ascendis Share Endocrinology Rare Disease Data at ESPE & ESE 2O25
    Ascendis Share Endocrinology Rare Disease Data at ESPE & ESE 2O25

    05 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/05/3074063/0/en/Ascendis-to-Share-Its-Latest-Endocrinology-Rare-Disease-Data-at-ESPE-ESE-2025.html

    GLOBENEWSWIRE
    05 May 2025
    Share Share